Multiple mechanisms of phase variation of PorA in Neisseria meningitidis

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 6685-6690

  Van Der Ende, Arie ^a   Hopman, Carla T P ^b   Dankert, Jacob ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; IMMUNOBLOTTING; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS;

BASE SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; PORINS; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS;

EID: 0034442206     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.6685-6690.2000     Document Type: Article

References (36)

1. Abdillahi, H., and J. T. Poolman. 1987. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48: 367-371.
2. Arhin, F. F., F. Moreau, J. W. Coulton, and E. L. Mills. 1998. Sequencing of porA from clinical isolates of Neisseria meningitidis defines a subtyping scheme and its genetic regulation. Can. J. Microbiol. 44:56-63.
3. Bart, A., J. Dankert, and A. van der Ende. 1999. Antigenic variation of the PorA outer membrane protein in hyperendemic Neisseria meningitidis strains in The Netherlands. Infect. Immun. 67:3842-3846.
4. Bjune, G., E. A. Hoiby, J. K. Gronnesby, O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A. K. Lindbak, H. Nokleby, E. Rosenqvist, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
5. Claassen, I., J. Meylis, P. van der Ley, C. Peeters, H. Brons, J. Robert, D. Borsboom, A. van der Ark, I. van Straaten, P. Roholl, B. Kuipers, and J. Poolman. 1996. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14:1001-1008.
6. DeHaseth, P., and J. D. Helmann. 1995. Open complex formation by Escherichia coli RNA polymerase: the mechanism of polymerase-induced strand separation of double helical DNA. Mol. Microbiol. 16:817-824.
7. Frasch, C. E., W. D. Zollinger, and J. T. Poolman. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:504-510.
8. Gotschlich, E. C. 1991. The meningococcal serogroup B vaccine protection trials: concluding remarks at the report meeting. NIPH Ann. 14:247-250.
9. Hammerschmidt, S., A. Muller, H. Sillmann, M. Muhlenhoff, R. Borrow, A. Fox, J. van Putten, W. D. Zollinger, R. Gerardy-Schahn, and M. Frosch. 1996. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol. Microbiol. 20:1211-1220.
10. Harley, C. B., and R. P. Reynolds. 1987. Analysis of E. coli promoter sequences. Nucleic Acids Res. 15:2343-2361.
11. Henderson, I. R., P. Owen, and J. P. Nataro. 1999. Molecular switches-the ON and OFF of bacterial phase variation. Mol. Microbiol. 33:919-932.
12. Herbert, M. A., P. T. Heath, and R. T. Mayon-White. 1995. Meningococcal vaccines for the United Kingdom. Communicable disease report. CDR Rev. 5:R130-R135.
13. Hopman, C. T. P., J. Dankert, and J. P. M. van Putten. 1994. Variable expression of the class 1 protein of Neisseria meningitidis, p. 513-517. In C. J. Conde-Glez, S. Morse, P. Rice, F. Sparling, and E. Calderon (ed.), Pathology and immunobiology of Neisseriaceae. Instituto Nacional de Salud Pública, Cuernavaca, Mexico.
14. Jennings, M. P., Y. N. Srikhanta, E. R. Moxon, M. Kramer, J. T. Poolman, B. Kuipers, and P. van der Ley. 1999. The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. Microbiology 145:3013-3021.
15. Jonsson, A. B., G. Nyberg, and S. Normark. 1991. Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly. EMBO J. 10:477-488.
16. Lewis, L. A., M. Gipson, K. Hartman, T. Ownbey, J. Vaughn, and D. W. Dyer. 1999. Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2. Mol. Microbiol. 32:977-989.
17. Maiden, M. C. J., J. Suker, A. J. McKenna, J. A. Bygraves, and I. M. Feavers. 1991. Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Mol. Microbiol. 5:727-736.
18. Makino, S., J. P. van Putten, and T. F. Meyer. 1991. Phase variation of the opacity outer membrane protein controls invasion by Neisseria gonorrhoeae into human epithelial cells. EMBO J. 10:1307-1315.
19. McGuiness, B. T., A. K. Barlow, I. N. Clarke, J. E. Farley, A. Anilionis, J. T. Poolman, D. M. Jones, and J. E. Heckels. 1990. Deduced amino acid sequences of class 1 protein (PorA) from 3 strains of Neisseria meningitidis: synthetic peptides define the epitopes responsible for serosubtype specificity. J. Exp. Med. 171:1871-1882.
20. McGuiness, B. T., I. N. Clarke, P. R. Lambden, A. K. Barlow, J. T. Poolman, D. M. Jones, and J. E. Heckels. 1991. Point mutation in meningococcal porA gene associated with increased endemic disease. Lancet 337:514-517.
21. Meyer, T. F., C. P. Gibbs, and R. Haas. 1990. Variation and control of protein expression in Neisseria. Annu. Rev. Microbiol. 44:451-477.
22. Milagres, L. G., M. C. A. Gorla, C. T. Sacchi, and M. M. Rodrigues. 1998. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine. Infect. Immun. 66:4755-4761.
23. Newcombe, J., K. Cartwright, S. Dyer, and J. McFadden. 1998. Naturally occurring insertional inactivation of the porA gene of Neisseria meningitidis by integration of IS1301. Mol. Microbiol. 30:453-454.
24. Peeters, C. C., H. C. Rumke, L. C. Sundermann, E. M. Rouppe van der Voort, J. Meulenbelt, M. Schuller, A. J. Kuipers, P. van der Ley, and J. T. Poolman. 1996. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14:1009-1015.
25. Poolman, J. T., C. T. P. Hopman, and H. C. Zanen. 1978, Immunochemical characterization of outer membrane complexes from Neisseria meningitidis by the SDS-polyacrylamide-gel-electrophoresis-immunoperoxidase technique (SGIP). FEMS Microbiol. Lett. 4:245-248.
26. Richardson, A. R., and I. Stojiljkovic. 1999. HmbR, a hemoglobin-binding outer membrane protein of Neisseria meningitidis, undergoes phase variation. J. Bacteriol. 181:2067-2074.
27. Saukkonen, K., H. Abdillahi, J. T. Poolman, and M. Leinonen. 1987. Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development. Microb. Pathog. 3:261-267.
28. Saukkonen, K., M. Leinonen, H. Abdillahi, and J. T. Poolman. 1989. Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine 7:325-328.
29. Sawaya, R., F. F. Arhin, F. Moreau, J. W. Coulton, and E. L. Mills. 1999. Mutational analysis of the promoter region of the porA gene of Neisseria meningitidis. Gene 233:49-57.
30. Siebenlist, U., R. B. Simpson, and W. Gilbert. 1980. E. coli RNA polymerase interacts homologously with two different promoters. Cell 20:269-281.
31. Suker, J., I. M. Feavers, and M. C. Maiden. 1996. Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design. Microbiology 142:63-69.
32. van Alphen, L., T. Riemens, J. Poolman, and H. C. Zanen. 1983. Characteristics of major outer membrane proteins of Haemophilus influenzae. J. Bacteriol. 155:878-885.
33. van der Ende, A., C. T. P. Hopman, S. Zaat, B. B. Oude Essink, B. Berkhout, and J. Dankert. 1995. Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between -10 and -35 regions of the promoter. J. Bacteriol. 177:2475-2480.
34. van der Ende, A., C. T. P. Hopman, and J. Dankert. 1999. Deletion of porA by recombination between clusters of repetitive extragenic palindromic sequences in Neisseria meningitidis. Infect. Immun. 67:2928-2934.
35. van der Ley, P. A., J. van der Biezen, and J. T. Poolman. 1995. Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine. Vaccine 13:401-407.
36. Warne, S. E., and P. L. DeHaseth. 1993. Promoter recognition by Escherichia coli RNA polymerase. Effects of single base pair deletions and insertions in the spacer DNA separating the -10 and -35 regions depend on spacer DNA sequence. Biochemistry 32:6134-6140.